A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease
- 1 July 1994
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 223 (2) , 589-593
- https://doi.org/10.1111/j.1432-1033.1994.tb19029.x
Abstract
Negative factor (Nef) protein from human immunodeficiency virus type 1 (HIV‐1) is cleaved into two well‐defined domains by the HIV‐1‐encoded protease. The cleavage site is located between Trp57 and Leu58 and is well conserved. The two domains are stable in the presence of protease for more than 48 h. The C‐terminal core domain contains a well‐conserved well‐folded region. The cleavage releases the core domain from the myristoylated membrane anchor domain. As is the case for other HIV proteins, cleavage of Nef could be crucial for correct biological function.Keywords
This publication has 38 references indexed in Scilit:
- Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1European Journal of Biochemistry, 1994
- Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1European Journal of Biochemistry, 1993
- Predicting cleavability of peptide sequences by HIV protease via correlation-angle approachProtein Journal, 1993
- Expression, purification and biochemical characterisation of the human immunodificiency virus 1 nef gene productEuropean Journal of Biochemistry, 1992
- In Vivo Derived HIV-1nefGene Products Are Heterogeneous and Lack Detectable Nucleotide Binding ActivityAIDS Research and Human Retroviruses, 1992
- Virological and cellular physiological roles of HIV Nef proteinResearch in Virology, 1992
- The HIV-1nefProtein Does Not Have Guanine Nucleotide Binding, GTPase, or Autophosphorylating ActivitiesAIDS Research and Human Retroviruses, 1991
- Importance of the nef gene for maintenance of high virus loads and for development of AIDSCell, 1991
- Serine phosphorylation-independent downregulation of cell-surface CD4 by nefNature, 1991
- Infectious Mutants of HTLV-III with Changes in the 3′ Region and Markedly Reduced Cytopathic EffectsScience, 1986